BIO
383.68 USD
-1.32%
Today
-0.30%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Bio-Rad Laboratories
Currency
USD
Market Cap
10.16B
Avg Daily Volume
7.00
52 Week High
379.5 USD
52 Week Low
244.54 USD
Trading Hours
See hours
Business Summary
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Top News
Agilent
+5.63%
BioRadLabs
+0.84%
Merck(US)
+2.79%
Electrophoresis Equipment and Supplies - Global Strategic Business Report 2026: Secure Share of a $3.1 Billion Market by 2032, Led by Agilent, Bio-Rad, SCIEX, and Merck
finance.yahoo.com
1d ago
BioRadLabs
+0.84%
Merck(US)
+2.79%
ThermoFish
+1.25%
Danaher
+1.95%
RoperTechn
+11.99%
Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption
finance.yahoo.com
1d ago
BioRadLabs
+0.84%
Bio Rad Laboratories (BIO) Stock Looks Fully Valued After 49% Five Year Fall
finance.yahoo.com
3d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
